Q1 2025 DaVita Inc Earnings Call Transcript
Key Points
- DaVita Inc (DVA) reported adjusted operating income and adjusted earnings per share slightly ahead of expectations, driven by strong expense management and profitability from phosphate binders.
- The partnership with the YMCA for chronic kidney disease education and prevention has shown promising early results, with 30% of participants found to have previously undiagnosed CKD.
- Despite a cybersecurity incident, DaVita Inc (DVA) maintained uninterrupted dialysis care for patients, demonstrating strong operational resilience.
- The company repurchased approximately $680 million of stock, indicating a commitment to returning capital to shareholders.
- International operations showed strong performance, contributing positively to the overall financial results.
- A cybersecurity incident disrupted operations, requiring remediation efforts and resulting in some regulatory and legal follow-ups.
- Treatment volume underperformed expectations, partly due to an abnormally high flu season and storms, leading to a 50-basis-point decline in treatments for the year.
- The company experienced a negative free cash flow of $45 million in the first quarter.
- The cyber incident and flu season are expected to have lingering impacts on treatment volumes and admissions.
- Integrated Kidney Care (IKC) reported operating losses of $29 million, with some volatility expected in this segment.
Good evening. My name is Michelle, and I will be your conference facilitator today. At this time, I would like to welcome everyone to the DaVita first-quarter 2025 earnings call. (Operator Instructions)
Mr. Eliason, you may begin your conference, sir.
Thank you, and welcome to our first-quarter conference call. I'm Nic Eliason, Group Vice President of Investor Relations. And joining me today are Javier Rodriguez, our CEO; and Joel Ackerman, our CFO.
Please note that during this call, we will make forward-looking statements within the meaning of the federal securities laws. All of these statements are subject to known and unknown risks and uncertainties that could cause the actual results to differ materially from those described in the forward-looking statements.
For further details concerning these risks and uncertainties, please refer to our first-quarter earnings press release and our SEC filings, including our most recent annual report on Form 10-K, all subsequent quarterly reports on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
